1. Home
  2. WVE vs HSTM Comparison

WVE vs HSTM Comparison

Compare WVE & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.88

Market Cap

744.8M

Sector

Health Care

ML Signal

N/A

Logo HealthStream Inc.

HSTM

HealthStream Inc.

N/A

Current Price

$30.36

Market Cap

814.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
HSTM
Founded
2012
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
814.2M
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
WVE
HSTM
Price
$3.88
$30.36
Analyst Decision
Strong Buy
Buy
Analyst Count
18
5
Target Price
$18.53
★ $34.50
AVG Volume (30 Days)
★ 2.8M
143.7K
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
★ 0.47%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.43
Revenue
$3,704,000.00
★ $304,064,000.00
Revenue This Year
$20.53
$8.31
Revenue Next Year
N/A
$4.59
P/E Ratio
★ N/A
$69.41
Revenue Growth
★ 149.43
4.26
52 Week Low
$3.56
$19.50
52 Week High
$21.73
$31.11

Technical Indicators

Market Signals
Indicator
WVE
HSTM
Relative Strength Index (RSI) 36.57 60.37
Support Level N/A $27.77
Resistance Level $6.33 $29.98
Average True Range (ATR) 0.21 0.64
MACD -0.02 0.04
Stochastic Oscillator 38.99 70.29

Price Performance

Historical Comparison
WVE
HSTM

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HSTM HealthStream Inc.

HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.

Share on Social Networks: